Intuitive Surgical, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Intuitive Surgical, Inc. (ISRG) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $255.71 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-07-21
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2026-03-31 was $240.02, a 0.42% increase year-over-year.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2025-03-31 was $239.02, a 4.40% decline year-over-year.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $250.01, a 5.37% decline year-over-year.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $264.19, a 16.75% increase year-over-year.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $244.38, a 4.76% decline from fiscal 2024.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $256.60, a 1.83% decline from fiscal 2023.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $261.39, a 8.90% increase from fiscal 2022.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $240.02, a 21.01% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $255.71 10-Q · filed 2026-07-21 | |||
| 2026-03-31 | $240.02 10-Q · filed 2026-04-22 | |||
| 2025-12-31 | $244.38 10-K · filed 2026-02-03 | |||
| 2025-09-30 | $244.44 10-Q · filed 2025-10-22 | |||
| 2025-06-30 | $241.29 10-Q · filed 2025-07-23 | |||
| 2025-03-31 | $239.02 10-Q · filed 2025-04-23 | |||
| 2024-12-31 | $256.60 10-K · filed 2025-01-31 | |||
| 2024-09-30 | $255.85 10-Q · filed 2024-10-18 | |||
| 2024-06-30 | $256.71 10-Q · filed 2024-07-19 | |||
| 2024-03-31 | $250.01 10-Q · filed 2024-04-19 | |||
| 2023-12-31 | $261.39 10-K · filed 2024-01-31 | |||
| 2023-09-30 | $259.12 10-Q · filed 2023-10-20 | |||
| 2023-06-30 | $254.12 10-Q · filed 2023-07-24 | |||
| 2023-03-31 | $264.19 10-Q · filed 2023-04-20 | |||
| 2022-12-31 | $240.02 10-K · filed 2023-02-10 | |||
| 2022-09-30 | $236.30 10-Q · filed 2022-10-21 | |||
| 2022-06-30 | $232.79 10-Q · filed 2022-07-22 | |||
| 2022-03-31 | $226.29 10-Q · filed 2022-04-22 | |||
| 2021-12-31 | $198.34 10-K · filed 2022-02-03 | |||
| 2021-09-30 | $194.12 10-Q · filed 2021-10-20 | |||
| 2021-06-30 | $564.48 10-Q · filed 2021-07-21 | |||
| 2021-03-31 | $572.55 10-Q · filed 2021-04-21 | |||
| 2020-12-31 | $490.77 10-K · filed 2021-02-10 | |||
| 2020-09-30 | $478.67 10-Q · filed 2020-10-19 | |||
| 2020-06-30 | $468.87 10-Q · filed 2020-07-23 | |||
| 2020-03-31 | $458.77 10-Q · filed 2020-04-17 | |||
| 2019-12-31 | $381.82 10-K · filed 2020-02-07 | |||
| 2019-09-30 | $344.13 10-Q · filed 2019-10-18 | |||
| 2019-06-30 | $327.95 10-Q · filed 2019-07-22 | |||
| 2019-03-31 | $337.41 10-Q · filed 2019-04-19 | |||
| 2018-12-31 | $237.05 10-K · filed 2019-02-04 | |||
| 2018-09-30 | $228.26 10-Q · filed 2018-10-22 | |||
| 2018-06-30 | $209.31 10-Q · filed 2018-07-20 | |||
| 2018-03-31 | $195.63 10-Q · filed 2018-04-18 | |||
| 2017-12-31 | $204.94 10-K · filed 2018-02-02 | |||
| 2017-09-30 | $193.50 10-Q · filed 2017-10-20 | |||
| 2017-06-30 | $571.80 10-Q · filed 2017-07-21 | |||
| 2017-03-31 | $563.79 10-Q · filed 2017-04-19 | |||
| 2016-12-31 | $494.64 10-K · filed 2017-02-06 | |||
| 2016-09-30 | $491.27 10-Q · filed 2016-10-19 | |||
| 2016-06-30 | $496.63 10-Q · filed 2016-07-20 | |||
| 2016-03-31 | $507.69 10-Q · filed 2016-04-19 | |||
| 2015-12-31 | $497.01 10-K · filed 2016-02-02 | |||
| 2015-09-30 | $496.02 10-Q · filed 2015-10-21 | |||
| 2015-06-30 | $494.38 10-Q · filed 2015-07-22 | |||
| 2015-03-31 | $502.58 10-Q · filed 2015-04-22 | |||
| 2014-12-31 | $478.19 10-K · filed 2015-02-06 | |||
| 2014-09-30 | $477.21 10-Q · filed 2014-10-23 | |||
| 2014-06-30 | $477.51 10-Q · filed 2014-07-24 | |||
| 2014-03-31 | $470.40 10-Q · filed 2014-04-25 | |||
| 2013-12-31 | $456.64 10-K · filed 2014-02-03 | |||
| 2013-09-30 | $456.31 10-Q · filed 2013-10-18 | |||
| 2013-06-30 | $447.18 10-Q · filed 2013-07-22 | |||
| 2012-12-31 | $371.29 10-K · filed 2013-02-04 | |||
| 2012-09-30 | $361.44 10-Q · filed 2012-10-18 | |||
| 2012-06-30 | $349.37 10-Q · filed 2012-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |